Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many

The New York Times – Business:

Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.

Rebecca Robbins and Carolyn Y. Johnson
Author: Rebecca Robbins and Carolyn Y. Johnson

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins and Carolyn Y. Johnson

in

Breast Cancer, Cancer, Clinical Trials, Drugs (Pharmaceuticals), Lung Cancer, Pancreas, Pancreatic Cancer, Research, Tumors
←‘The Whisper Man’ Review: Robert De Niro Tries to Crack a Grisly Case
Harry Styles Fans Camp Out for the Best View of the Star→

More posts

  • Policymakers watch Anthropic IPO with wary eye

  • One last fight over permitting?

  • Massachusetts gov says Dems want ‘a uniter and a fighter’ for 2028

  • Here are the GTA 6 songs you’ll hear cruising around Vice City

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube